Interlaboratory Analysis of Isavuconazole Plasma Concentration Assays Among European Laboratories

Federico Pea1, Robert Krause2, Carsten Müller3

  • 1Department of Medicine, University of Udine, and Institute of Clinical Pharmacology, Santa Maria della Misericordia University Hospital, ASUIUD, Udine, Italy.

Abstract

Insights

This study evaluated isavuconazole plasma concentration assays across 27 labs. Results show significant variability, indicating a need for standardized methods to ensure accurate therapeutic drug monitoring for fungal infections.

Area of Science:

  • Clinical Chemistry
  • Pharmacology
  • Mycology

Background:

  • Clinicians may monitor isavuconazole levels for invasive aspergillosis and mucormycosis.
  • The accuracy and reproducibility of laboratory assays for isavuconazole plasma concentrations are not well-established.

Purpose of the Study:

  • To assess the accuracy and reproducibility of isavuconazole plasma concentration quantification across multiple European laboratories.
  • To compare different assay methods, including LC-MS/MS, LC-UV, LC-FL, and bioassay.

Main Methods:

  • A round-robin study involving 27 European laboratories was conducted.
  • Human plasma samples with known isavuconazole concentrations were analyzed in two independent rounds.
  • Assay methods used were liquid chromatography-tandem mass spectrometry (LC-MS/MS), LC with ultraviolet detection (LC-UV), LC with fluorescence detection (LC-FL), and bioassay.

Main Results:

  • Determined concentrations generally aligned with nominal values, but with significant inter-laboratory and inter-assay variability.
  • Ten laboratories consistently reported concentrations within 15% of nominal values.
  • Seven laboratories consistently exceeded the upper 15% margin, highlighting potential accuracy issues.

Conclusions:

  • There is a need to align methodologies among laboratories to improve the accuracy and reproducibility of isavuconazole therapeutic drug measurements.
  • Standardization is crucial for reliable therapeutic drug monitoring in patients treated with isavuconazole.

Related Concept Videos

Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
181
Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
258
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
236
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
229
In Vitro Drug Dissolution: Compendial Testing Models II01:09

In Vitro Drug Dissolution: Compendial Testing Models II

Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients,...
266
In Vitro Drug Dissolution: Compendial Testing Models I01:13

In Vitro Drug Dissolution: Compendial Testing Models I

Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
237